Atlas Trials

Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy

Clinical trial NCT07597733 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07597733
Sponsor
Sichuan Academy of Medical Sciences
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Refractory Chronic Inflammatory Demyelinating Polyneuropathy
Start date
2025-09-26
Primary completion
2027-08-31
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.